Concepedia

R Fitzpatrick

RF

Statistics

Publications

10

Citations

412

H-Index

10

Active since

1988

Affiliations

Keele University(Current)

University of Mosul

R Fitzpatrick is an author at Keele University specializing in market access for biosimilars, pharmacy, and access to biosimilars.

ORCID

Publications per year

1988–2019

10

Publications

10

Impact of Infliximab and Etanercept Biosimilars on Biological Disease-Modifying Antirheumatic Drugs Utilisation and NHS Budget in the UK

Mohammed Aladul, R Fitzpatrick, Stephen Chapman · BioDrugs · 2017 · 66 citations · Full text

, , +16

Results of EAHP’s 2018 Survey on Medicines Shortages

Nenad Miljković, Nicholas Gibbons, Aida Batista et al. · European Journal of Hospital Pharmacy · 2019 · 59 citations · Full text

, , +14

Healthcare professionals’ perceptions and perspectives on biosimilar medicines and the barriers and facilitators to their prescribing in UK: a qualitative study

Mohammed Aladul, R Fitzpatrick, Stephen Chapman · BMJ Open · 2018 · 56 citations · Full text

, , +9

Patients with cancer holding their own records: a randomised controlled trial.

M. I. Drury, P Yudkin, Jean Harcourt et al. · PubMed · 2000 · 51 citations

, , +15

Knowledge, attitude and practice of healthcare professionals towards infliximab and insulin glargine biosimilars: result of a UK web-based survey

Stephen Chapman, R Fitzpatrick, Mohammed Aladul · BMJ Open · 2017 · 51 citations · Full text

, , +15

1–5 of 10